Level of C-Reactive Protein in Chronic Hemodialysis Patients: A Comparative Study Between Patients With Non-Infected Catheters and Arteriovenous Fistula in a Large Saudi Hemodialysis Center

Therapeutic Apheresis and Dialysis

Volumn 17, Issue 1, 2013, Pages 35-39

  Al Saran, Khalid ^a   Sabry, Alaa ^b   Shalaby, Medhat ^a   Al Sherbeiny, Sherrine ^a   Abdelkader, Mohamed ^a  

^a Prince Salman Center for Kidney Disease   (Saudi Arabia)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Access; C reactive protein; Hemodialysis; Inflammation

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; HEMOGLOBIN; PHOSPHORUS;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS FISTULA; ARTICLE; CALCIUM BLOOD LEVEL; CENTRAL VENOUS CATHETER; COMPARATIVE STUDY; FEMALE; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTRAVENOUS CATHETER; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; SAUDI ARABIA; TREATMENT DURATION; TURBIDIMETRY;

ADULT; AGED; AGED, 80 AND OVER; ARTERIOVENOUS SHUNT, SURGICAL; C-REACTIVE PROTEIN; CENTRAL VENOUS CATHETERS; FEMALE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; PROSPECTIVE STUDIES; RENAL DIALYSIS; SAUDI ARABIA; YOUNG ADULT;

EID: 84873447564     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2012.01116.x     Document Type: Article

References (18)

1. Pearson TA, Mensah GA, Alexander RW etal. Markers of inflammation and cardiovascular disease: application to clinical and public: a statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003;107:499-511.
2. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-9.
3. Cook NR, Buring JE, Ridker PM. The effect of including C-reactive protein in cardiovascular risk prediction models for women. Ann Intern Med 2006;145:21-9.
4. Pepys MB, Hirschield GM. C-reactive protein: a critical update. J Clin Invest 2003;111:1805-12.
5. Stenvinkel P, Heimbuger O, Paultre F etal. Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 1999;55:1899-911.
6. Ammirati AL, Dalboni MA, Cendoroglo M, Draibe SA, Fernandes Canziani ME. Coronary artery calcification, systemic inflammation markers and mineral metabolism in peritoneal dialysis population. Nephron Clin Pract 2006;104:c33-c40.
7. Stuart G, Ikizler TA, Zappitelli M, etal. Non-infected hemodialysis catheters are associated with increased inflammation compared to arteriovenous fistulas. Kidney Int 2009;76:1063-9.
8. Ikizler TA, Wingard RL, Harvell J, Shyr Y, Hakim RM. Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study. Kidney Int 1999;55:1945-51.
9. Zimmermann J, Herrlinger S, Pruy A, Metzger T, Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 1999;55:648-58.
10. Yeun JY, Levine RA, Mantadilok V, Kaysen GA. C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2000;35:469-76.
11. Rehman R, Schmidt RJ, Moss AH. Ethical and legal obligation to avoid long-term tunneled catheter. Clin J Am Soc Nephrol 2009;4:456-60.
12. Allon M, Daugirdas J, Depner TA etal. Effect of change in vascular access on patient mortality in hemodialysis patients. Am J Kidney Dis 2006;47:469-77.
13. Nassar GM, Ayus JC. Infection complications of hemodialysis access. Kidney Int 2001;60:1-13.
14. Movilli E, Brunori G, Camerini C etal. The kind of vascular access influences the baseline inflammatory status and epoetin response in chronic hemodialysis patients. Blood Purif 2006;24:387-93.
15. Hung A, Pupim L, Yu C etal. Determinants of C- reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization. Hemodial Int 2008;12:236-43.
16. Collins AJ, Foley R, Herzog C etal. Excepts from the United States renal data system 2007 annual data report. Am J Kidney Dis 2008;51:S1-320.
17. Kaysen GA, Dubin JA, Muller HG, Rosales LM, Levin NW. The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. The HEMO study group. Kidney Int 2000;58:346-52.
18. Tsirpanlis G, Bagos P, Ioannou D etal. Exploring inflammation in hemodialysis patients: persistent and superimposed inflammation. A longitudinal study. Kidney Blood Press Res 2004;27:63-70.